Trial NCT03996473

View at ClinicalTrials.gov 
Org. Study IDs: 19781
Secondary IDs: 2018-003704-39

Last trial update was posted on 2023-03-06

MeSH Interventions

Pembrolizumab Radium Ra 223 dichloride

MeSH Conditions

Carcinoma, Non-Small-Cell Lung

Other Conditions


Stopping Reasons

LPLV reached on 30Jan2023. Study was closed early for feasibility reasons related to enrollment of first line IO naïve patients. Safety data is consistent with the known safety profile of both drugs and no new safety issues have been observed

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID